Toyama, Japan

Yasuko Kawaguchi

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Taisho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd.. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuko Kawaguchi. Retrieved from https://idiyas.com/inventor/yasuko-kawaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0


 

Average Co-Inventor Count = 10.5

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Yasuko Kawaguchi - Revolutionizing Technology in Toyama

Introduction: Yasuko Kawaguchi is a pioneering inventor hailing from Toyama, Japan, known for her groundbreaking contributions to the field of technology.

Latest Patents: Yasuko Kawaguchi holds several patents in the realm of robotics and artificial intelligence, showcasing her innovative mindset and dedication to advancing these fields.

Career Highlights: With a career spanning over two decades, Yasuko Kawaguchi has worked with top research institutions and tech companies, leading the development of cutting-edge technologies that have reshaped industries.

Collaborations: Throughout her career, Yasuko Kawaguchi has collaborated with renowned engineers, scientists, and inventors, fostering a culture of innovation and knowledge-sharing to drive progress in the tech sector.

Conclusion: Yasuko Kawaguchi's relentless pursuit of innovation and her passion for pushing the boundaries of technology make her a true trailblazer in the world of inventions, inspiring future generations of inventors to dream big and create change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…